Table 3.
A IDD-plus-SRAD N=4220 |
B IDD-non-SRAD N=62 264 |
C SRAD-non-DD N=96 589 |
Cohen's d* (95% CI) |
|||
---|---|---|---|---|---|---|
A vs B | A vs C | B vs C | ||||
Chronic physical illness | ||||||
Diabetes | 12.6 | 9.8 | 6.5 | 0.16 (0.10 to 0.21) | 0.40 (0.35 to 0.45) | 0.25 (0.23 to 0.27) |
Hypertension | 15.3 | 13.8 | 13.2 | 0.07 (0.02 to 0.11) | 0.09 (0.05 to 0.14) | 0.03 (0.01 to 0.04) |
COPD | 13.6 | 5.2 | 8.5 | 0.58 (0.53 to 0.63) | 0.29 (0.24 to 0.34) | −0.29 (−0.31 to −0.27) |
Asthma | 27.3 | 16.5 | 18.0 | 0.35 (0.31 to 0.39) | 0.30 (0.26 to 0.33) | −0.06 (−0.07 to −0.04) |
Congestive heart failure | 2.0 | 1.0 | 0.7 | 0.39 (0.26 to 0.51) | 0.59 (0.46 to 0.71) | 0.20 (0.14 to 026) |
Morbidity | ||||||
Per cent of high/very high morbidity | 59.5 | 21.6 | 43.2 | 00.92 (0.89 to 0.96) | 0.36 (0.33 to 0.40) | −0.56 (−0.57 to −0.55) |
*Cells with effect sizes ≥0.2 and 95% CIs which do not go below 0.2 are in bold.
COPD, chronic obstructive pulmonary disorder; IDD, intellectual and developmental disabilities; SRAD, substance-related and addictive disorders.